基于态靶因果理论治疗高血压的研究进展
Research Progress in the Treatment of Hypertension Based on the Theory of State-Target Causality
DOI: 10.12677/acm.2025.15113076, PDF,   
作者: 李 蕾:黑龙江中医药大学研究生院,黑龙江 哈尔滨;客 蕊*:黑龙江中医药大学附属第一医院老年病科,黑龙江 哈尔滨
关键词: 态靶因果高血压研究进展综述State-Target Causality Hypertension Research Progress Review
摘要: 随着生活水平的不断提高,人们的饮食结构也在不断发生变化,高血压病人的数量越来越多。现代医学治疗高血压,常采用抗高血压药物进行治疗,尽管高血压的治疗技术和手段在不断进步,但当前高血压的管理状况仍不容乐观。中医凭借其辨证论治的个体化诊疗思维,以及中药多靶点、整体调节的作用机制,在高血压病的治疗体系中占有一席之地,展现出重要的临床应用价值。仝小林教授于2015年提出了“态靶理论”,后完善为态靶因果。态靶因果理论“以病为纬、以态为经、微观定靶、察因态、重果态”的诊疗策略为临床治疗高血压病这一难题提供了新的思路。在态靶因果理论的指导下,医生在临床实践中也能更灵活地探讨中医药治疗高血压病的症状、证候等方面的机制和效用,把握疾病的核心病机和发展态势,精准用药。提高了临床治疗的有效性和精准性。
Abstract: With the continuous improvement of living standards, people’s dietary structure is constantly changing, and the number of patients with hypertension is increasing. Modern medicine often uses antihypertensive drugs to treat hypertension. Although the treatment techniques and methods for hypertension are constantly improving, the current management situation of hypertension is still not optimistic. Traditional Chinese medicine, with its individualized diagnosis and treatment thinking based on syndrome differentiation and treatment, as well as the multi-target and holistic regulatory mechanism of traditional Chinese medicine, occupies a place in the treatment system of hypertension and demonstrates important clinical application value. Professor Tong Xiaolin proposed the “state-target Theory” in 2015, which was later refined into state-target causality. The diagnosis and treatment strategy of the “state-target causality theory”, which takes disease as the latitude, state as the longitude, micro-level target determination, cause-state observation, and result-state emphasis, provides a new approach for the clinical treatment of hypertension, a difficult problem. Under the guidance of the target-state causality theory, doctors can also more flexibly explore the mechanisms and efficacy of traditional Chinese medicine in treating the symptoms and syndromes of hypertension in clinical practice, grasp the core pathogenesis and development trend of the disease, and use drugs precisely. It has improved the effectiveness and accuracy of clinical treatment.
文章引用:李蕾, 客蕊. 基于态靶因果理论治疗高血压的研究进展[J]. 临床医学进展, 2025, 15(11): 132-138. https://doi.org/10.12677/acm.2025.15113076

参考文献

[1] Desai, A.N. (2020) High Blood Pressure. JAMA, 324, 1254-1255. [Google Scholar] [CrossRef] [PubMed]
[2] 孙芹, 田伟帆, 罗婷婷, 等. 2023年世界卫生组织《全球高血压报告》解读[J]. 中国胸心血管外科临床杂志, 2024, 31(2): 203-208.
[3] Cao, X., Wang, X., Tian, Y., Tuerdi, N., Zheng, C., Li, W., et al. (2025) Trends and Sociodemographic Patterns in Hypertension Prevalence and Treatment in China. Med, 2025, Article ID: 100808. [Google Scholar] [CrossRef] [PubMed]
[4] 仝小林, 何莉莎, 赵林华. 助力精准医学: 表型组学与中医学的借鉴与融合[J]. 中国中西医结合杂志, 2018, 38(3): 368-370.
[5] 仝小林. 态靶医学——中医未来发展之路[J]. 中国中西医结合杂志, 2021, 41(1): 16-18.
[6] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[7] 杨红霞, 景策, 刘睿, 等. 高血压发病机制研究进展[J]. 医学综述, 2019, 25(22): 4483-4487.
[8] Desai, A.S., Webb, D.J., Taubel, J., Casey, S., Cheng, Y., Robbie, G.J., et al. (2023) Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. New England Journal of Medicine, 389, 228-238. [Google Scholar] [CrossRef] [PubMed]
[9] 刘亚荣, 范虹, 雷忠义, 等. 国医大师雷忠义治疗高血压病经验[J]. 现代中医药, 2025, 45(1): 61-65.
[10] 仝小林, 何莉莎, 赵林华. 论“态靶因果”中医临床辨治方略[J]. 中医杂志, 2015, 56(17): 1441-1444.
[11] 魏秀秀, 仝小林, 杨映映, 等. 仝小林院士辨治高血压病“三期五态”新视角[J]. 中医学报, 2020, 35(1): 90-94.
[12] 杨映映, 魏秀秀, 王天铬, 等. 仝小林“三期六态”高血压病辨治经验[J]. 中华中医药杂志, 2020, 35(6): 2949-2953.
[13] Liu, H., Cheng, Y., Chu, J., Wu, M., Yan, M., Wang, D., et al. (2021) Baicalin Attenuates Angiotensin II-Induced Blood Pressure Elevation and Modulates MLCK/p-MLC Signaling Pathway. Biomedicine & Pharmacotherapy, 143, Article ID: 112124. [Google Scholar] [CrossRef] [PubMed]
[14] 苏轶琰, 胡泽琦, 褚振亮, 等. 泽泻治疗高血压病的研究概述[J]. 浙江中医杂志, 2025, 60(2): 183-185.
[15] 刘月程, 左振宇, 杜晓蕾, 等. 钩藤类方干预高血压肝阳上亢证大鼠的方证相关研究[J]. 药学学报, 2025, 60(7): 2271-2282.
[16] 孟婷婷, 高红丽, 高祎凡, 等. 姜黄素对长期高盐诱导高血压大鼠中枢的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(12): 1357-1364.
[17] 靳亚弟, 艾对元, 赵可, 等. 当归-灵芝对高血压治疗的药理学研究[J]. 核农学报, 2025, 39(6): 1137-1147.
[18] 李东娜, 司香环, 李宏佳, 等. 基于网络药理学及实验验证探讨罗布麻叶-钩藤药对治疗高血压病的作用机制[J]. 新中医, 2024, 56(2): 177-185.
[19] 钟思凡, 陶源, 兰松博, 等. 天麻-丹参药对治疗高血压作用机制的网络药理学分析及实验验证[J]. 中药新药与临床药理, 2024, 35(3): 384-393.
[20] 高华健, 林珊, 鲁竹青, 等. 天麻钩藤药对减轻高血压小鼠心脏炎症及改善射血功能的研究[J]. 福建中医药, 2022, 53(12): 27-30.
[21] 管怡晴, 陈凯, 田元新, 等. 基于网络药理学分析黄芩-槐花药对治疗高血压的作用机制[J]. 医药导报, 2021, 40(6): 715-722.
[22] 施之琪, 王卿, 陆曙. 基于网络药理学和动物实验探讨降防保心胶囊治疗高血压的药效和作用机制[J]. 中国医院药学杂志, 2025, 45(15): 1693-1699, 1713.
[23] 王俊超, 王建波, 张云雨, 等. 从自噬角度探析补阳还五汤防治高血压病的作用机制[J]. 实用中医内科杂志, 2025, 39(6): 139-142.
[24] 蒋欣琪, 卢涛, 于国华, 等. 基于网络药理学探讨知柏地黄丸治疗高血压的作用机制[J]. 西部中医药, 2025, 38(5): 38-46.
[25] 秦钦, 时拥月, 姚佳梅, 等. 天麻钩藤饮对自发性高血压大鼠p38 MAPK/HSP27通路影响的研究[J]. 北京中医药大学学报, 2023, 46(12): 1694-1705.
[26] 董春娇, 郝唯, 杨思雯, 等. 基于网络药理学分析吴茱萸汤治疗高血压的作用机制[J]. 中国当代医药, 2025, 32(14): 15-20, 25.
[27] 董新蕾, 闫钦风, 汶健, 等. 针刺对高血压靶器官保护的信号通路及调控机制研究探析[J]. 针灸临床杂志, 2025, 41(2): 1-9.
[28] 刘巍, 杜宇征, 孟祥刚, 等. 石学敏院士治疗高血压病捻转补泻手法浅析[J]. 中国针灸, 2021, 41(10): 1135-1139.
[29] 肖亚康. 八式太极拳运动对原发性高血压患者血压水平、血管内皮功能及生活质量的影响[J]. 中国老年学杂志, 2018, 38(10): 2403-2405.
[30] Li, J., Yang, Z., Zhang, C., Hu, Y., Li, H., Zhang, M., et al. (2022) Chinese Classical Music Lowers Blood Pressure and Improves Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats. Frontiers in Pharmacology, 13, Article ID: 826669. [Google Scholar] [CrossRef] [PubMed]